GlassScriptPhysician profile
Michael Ray Delong
NPI 1104246339
$2,474.50
in general payments reported to CMS, 2019-2025
10 companies · $890 in 2025
The $890 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $55.93 · 2022: $307 · 2023: $291 · 2024: $930 · 2025: $890.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,873 · Travel and Lodging: $239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,872.65 |
| Travel and Lodging | $239.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $830.35 | 2021-2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Ha+ Nerve Protector |
| Becton, Dickinson and Company | $365.34 | 2025 | Phasix Mesh, Arista |
| Mentor Worldwide LLC | $292.87 | 2021-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander, Mentor Cpx 2 Breast Tissue Expander |
| Musculoskeletal Transplant Foundation INC. | $201.53 | 2022-2025 | |
| Polynovo North America LLC | $175.20 | 2023 | |
| Rti Surgical, INC | $153.75 | 2025 | |
| Abbvie INC. | $145.47 | 2024 | |
| Davol INC. | $142.29 | 2025 | Phasix Mesh |
| 3d Systems | $103.33 | 2024 | |
| Biocircuit Technologies INC | $64.37 | 2025 | Nerve Tape |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Delong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.